Medical Imaging Reagents Market Expected to Reach $17.32 Billion by 2027

Medical imaging reagents market size was valued at $11,698 million in 2019, and is projected to reach $17,329 million by 2027, registering a CAGR of 5.0% from 2019 to 2027.

Medical imaging reagents are chemicals that improve image developed through imaging equipment. With the use of these reagents, doctors can detect presence of a tumor and measure if it is benign or malignant, and can trace any cancerous spot in the body. Enhancement in medical imaging reagents include synthesizing it to target a biological process. Imaging systems are then adjusted to these enhancements to counteract a particular target. These imaging reagents are first tested on animals before using on humans. There are three types of medical imaging reagents, which include contrast reagents, optical reagents, and nuclear reagents.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
The global medical imaging reagents market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum medical imaging reagents market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Bayer AG, Bracco SpA, Cardinal Health, Eli Lilly and Company, General Electric Company (GE Healthcare), Lantheus Holdings, Inc., LI-COR Biosciences Inc., Merck KGaA (Sigma-Aldrich), PerkinElmer, Inc., and Thermo Fisher Scientific Inc.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1664

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
By class, the contrast segment occupied more than half of the share of global medical imaging reagents market in 2019
By application, the drug discovery and development segment occupied around two-fifth share of the global medical imaging reagents market in 2019.
By technology, the nanoparticles segment is expected to exhibit highest CAGR during the forecast period.
By region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/1664

The contrast reagents segment dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. Key factors such as increase in approvals for contrast reagents and rise in establishment of a number of public & private diagnostic centers and rise in prevalence of cardiovascular disease, increase in demand for contrast reagents, and advantages such as better image quality and detection of any disorder in the body boost the medical imaging reagents market growth.

On the basis of technology, the market is classified into nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. The nanoparticles segment accounted for the maximum market revenue and was the fastest growing segment in 2019, and is anticipated to maintain its dominant position during the forecast period. This is attributed to rise in demand for nanoparticles in medical imaging technology, rise in use of nanoparticles in targeted cancer imaging, technological advancements in nanotechnology, and surge in support of governmental and non-governmental authorities to increase public enrollment associated with early disease diagnosis.

North America accounted for the largest share of the global medical imaging reagents market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to rise in prevalence of cardiovascular & neurological diseases and cancer and growth in awareness related to advanced imaging reagents. Moreover, rise in geriatric population, large number of target population with higher health awareness, and availability of trained medical professionals are other factors that fuel growth of the market. Asia-Pacific is expected to experience highest growth rate during the forecast period, majorly owing to increase in number of medical imaging procedures and surge in adoption of medical imaging reagents in advanced diagnostic imaging procedures.

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.